EUVIMEDEUVIMED entdecken
Crossref

Melanocytic clefting is associated with melanoma on LC ‐ OCT

J Pérez-Anker iD, S Soglia iD, S Puig iD, A García, R Albero, B Alejo, E Cinotti iD, C Orte Cano iD, C Habougit, F Skowron, L Pellegrino, L Tognetti iD und 8 weitere

Journal of the European Academy of Dermatology and Venereology · 2025

DOI: 10.1111/jdv.20761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2025. Verfasst von J Pérez-Anker und 19 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Tomography, Optical Coherence, Melanocytes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: CIBER de Enfermedades Raras of the Instituto de Salud Carlos III, Spain, AGAUR, CERCA Programme by Generalitat de Catalunya, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Line‐field confocal optical coherence tomography (LC‐OCT) provides in vivo images with cellular resolution for melanocytic lesions. To date, no descriptions have associated cellular discohesion forming clefts (‘clefting’) with malignancy in melanocytic lesions using in vivo imaging techniques such as reflectance confocal microscopy (RCM) or LC‐OCT.

Objectives

This study aimed to describe the feature of ‘clefting’ in melanocytic lesions and its correlation with histopathology and RCM.

Methods

Consecutive benign, atypical and malignant melanocytic lesions were scanned with LC‐OCT at the Hospital Clinic of Barcelona, Hôpital Erasme and University Hospital of Saint‐Etienne. Images of body and facial lesions were reviewed according to study criteria. Only lesions with a univocal or unambiguous diagnosis (clinically or histologically) were selected.

Results

Clefting was found in 36 of the 200 analysed lesions. It was present in 28 of the 70 melanomas (40%) and in eight of the 130 benign lesions (6%). The odds ratio for malignancy associated with the presence of clefting in a melanocytic lesion was 10.03 (CI 4.07–27.5; p < 0.001). The magnitude of clefting also showed significant differences: marked clefting was present in 17 of the 70 melanomas (24%) and in only two benign lesions (2%), with an OR of 20.22 (CI 4.55–186.2; p < 0.001). No differences were observed regarding the presence of this feature in different locations. It was strongly associated with other malignant features, such as epidermal consumption, nests in the epidermis and disruption of the dermo‐epidermal junction.

Conclusions

This study highlights that clefting observed in melanocytic lesions is not an artefact created by sample preparation, but a specific feature related to malignancy. Moreover, marked clefting is apparently associated with deeper melanoma invasion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsTomography, Optical CoherenceMelanocytesHumansFemaleMaleMiddle AgedAdultAgedAged, 80 and overNevus, Pigmented

Autor:innen und Institutionen

  • Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Universitat de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
  • Pathology Department, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
  • Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
  • Groupe d'Imagerie Cutanée Non Invasive (GICNI) of the Société Française de Dermatologie (SFD), Paris, France.

ORCID-Profile: J Pérez-Anker, S Soglia, S Puig, E Cinotti, C Orte Cano, L Tognetti, C Lenoir, P Castillo, M Suppa, J Malvehy

Förderung

  • CIBER de Enfermedades Raras of the Instituto de Salud Carlos III, Spain
  • AGAUR
  • CERCA Programme by Generalitat de Catalunya, Spain
  • Fundación Científica de la Asociación Española Contra el Cáncer
  • Fondo de Investigaciones Sanitarias
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Fundación Científica Asociación Española Contra el Cáncer

Zitieren

APA

Pérez-Anker, J., Soglia, S., Puig, S., García, A., Albero, R., Alejo, B., Cinotti, E., Orte Cano, C., Habougit, C., Skowron, F., Pellegrino, L., Tognetti, L., Lenoir, C., Castillo, P., Rubegni, P., Suppa, M., Perrot, J. L., Del Marmol, V., Alòs, L., & Malvehy, J. (2025). Melanocytic clefting is associated with melanoma on LC ‐ OCT. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.20761

Vancouver

Pérez-Anker J, Soglia S, Puig S, García A, Albero R, Alejo B, et al. Melanocytic clefting is associated with melanoma on LC ‐ OCT. Journal of the European Academy of Dermatology and Venereology. 2025. doi:10.1111/jdv.20761

BibTeX
@article{PrezAnker2025,
  author = {Pérez-Anker, J and Soglia, S and Puig, S and García, A and Albero, R and Alejo, B and Cinotti, E and Orte Cano, C and Habougit, C and Skowron, F and Pellegrino, L and Tognetti, L and Lenoir, C and Castillo, P and Rubegni, P and Suppa, M and Perrot, J L and Del Marmol, V and Alòs, L and Malvehy, J},
  title = {Melanocytic clefting is associated with melanoma on LC ‐ OCT},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  doi = {10.1111/jdv.20761}
}
Kostenlos starten →